MURFREESBORO, TN / ACCESSWIRE / January 28, 2020 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the fourth quarter ended December 31, 2019. NHI plans to issue its earnings release before the market opens on Wednesday, February 19, 2020, and will host a conference call that day at 12 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (800) 582-1443, with the confirmation number 21950888.
The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/32769 on Wednesday, February 19, 2020, at 12 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for approximately 90 days.
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.
Contact: Dana Hambly
Director, Investor Relations
Phone: (615) 890-9100
SOURCE: National Health Investors via EQS Newswire
View source version on accesswire.com:
https://www.accesswire.com/574389/NHI-Announces-Fourth-Quarter-2019-Earnings-Release-and-Conference-Call-Date
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…